StemRIM is a bio company that aims to develop "regeneration-inducing medicines".
Business Model:
Revenue: $944.5k
Employees: 11-50
Address:
City: Osaka
State: Osaka
Zip:
Country: Japan
Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.
Contact Phone:
Contact Email:
Listed Exchange:
Tokyo Stock Exchange
IPO Date:
8/9/2019
Ticker Symbol:
4599
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Venture Round | 6 | $6.8M |
KSP Kyogin Lease &a; Capital M3 M3i Miyako Capital SMBC Venture Capital KSP Kyogin Lease &a; Capital M3 M3i Miyako Capital SMBC Venture Capital |
12/2018 | Venture Round | 1 | $6.2M |
DCI Partners DCI Partners |
12/2017 | Venture Round | 1 | $1.8M |
Mitsubishi UFJ Capital Mitsubishi UFJ Capital |
11/2017 | Venture Round | 10 | $9M |
KSP Kyogin Lease &a; Capital M3 M3i Miyako Capital Mizuho Capital Nippon Venture Capital SMBC Nikko Securities Japan SMBC Venture Capital Sosei CVC KSP Kyogin Lease &a; Capital M3 M3i Miyako Capital Mizuho Capital Nippon Venture Capital SMBC Nikko Securities Japan SMBC Venture Capital Sosei CVC |
12/2014 | Corporate Round | 1 | $6.8M |
Shionogi Shionogi |
8/2019 | IPO | - | 8/2019 | IPO | - |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|